Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

NCT02559089 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.

NCT NCT02559089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02559089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China
Lead sponsor
Beijing Tongren Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2015
Completion date
Not reported
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anti-nmda receptor enphalitis